Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
4
Bullish
6
Bearish
36
Neutral
4
Bullish
6
Bearish
32
Neutral
0
Bullish
0
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
Market Cap
₹ 246 Cr
P/E
25.18
Pharmaceuticals
Pharmaceuticals - Indian - Formulations
246 Cr
High Risk
25.2
43.8
0.3
4.8
241.95
130.20
Sales CAGR
1Y
27.37%
3Y
46.40%
5Y
—
10Y
—
Profit CAGR
1Y
55.63%
3Y
91.99%
5Y
—
10Y
—
ROE
TTM
23.68%
3Y
29.01%
5Y
—
10Y
—
ROCE
TTM
31.80%
3Y
38.65%
5Y
—
10Y
—
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
EXCEPTIONAL
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
HIGH RISK